Daniel H Silverman

Title(s)HS Clinical Professor, Molecular and Medical Pharmacology
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Acute and Long-Term Effects of Chemotherapy on Regional Cerebral Metabolism
    NIH R21NS071385Sep 30, 2011 - Aug 31, 2014
    Role: Principal Investigator
    Evaluation of Presynaptic Calcium Channels In Vivo
    NIH R21MH064679Apr 1, 2002 - Mar 31, 2005
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology. Front Neurol. 2023; 14:1241638. Hickman LB, Stern JM, Silverman DHS, Salamon N, Vossel K. PMID: 37830092; PMCID: PMC10565489.
      View in: PubMed   Mentions:
    2. Sleep Disturbance in Tourette's Disorder: Potential Underlying Mechanisms. Curr Sleep Med Rep. 2023 Mar; 9(1):10-22. Ricketts EJ, Swisher V, Greene DJ, Silverman D, Nofzinger EA, Colwell CS. PMID: 37636897; PMCID: PMC10457082.
      View in: PubMed   Mentions:
    3. Reply: Posterior Cingulate Involvement Does Not Argue Against LATE-And Who Said It Does? J Nucl Med. 2022 08; 63(8):1283-1284. Rieger AC, Silverman DHS. PMID: 35710736.
      View in: PubMed   Mentions:    Fields:    
    4. Is It Too Soon to Know When It's LATE? J Nucl Med. 2022 Feb; 63(2):180-182. Rieger AC, Silverman DHS. PMID: 35101927.
      View in: PubMed   Mentions: 1     Fields:    
    5. A minority of patients with functional seizures have abnormalities on neuroimaging. J Neurol Sci. 2021 Aug 15; 427:117548. Kerr WT, Lee JK, Karimi AH, Tatekawa H, Hickman LB, Connerney M, Sreenivasan SS, Dubey I, Allas CH, Smith JM, Savic I, Silverman DHS, Hadjiiski LM, Beimer NJ, Stacey WC, Cohen MS, Engel J, Feusner JD, Salamon N, Stern JM. PMID: 34216975.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Examining posttraumatic stress disorder as a key postinjury risk factor in OIF/OEF veterans with blast-induced mild traumatic brain injury. Neuropsychology. 2020 Sep; 34(6):713-725. Kim SH, Lee N, Martin B, Suh J, Walters D, Silverman DH, Berenji GR. PMID: 32614198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Brain Metabolism During A Lower Extremity Voluntary Movement Task in Children With Spastic Cerebral Palsy. Front Hum Neurosci. 2020; 14:159. Fowler EG, Oppenheim WL, Greenberg MB, Staudt LA, Joshi SH, Silverman DHS. PMID: 32528261; PMCID: PMC7263017.
      View in: PubMed   Mentions: 2  
    8. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders. J Alzheimers Dis. 2020; 77(3):935-947. Raji CA, Torosyan N, Silverman DHS. PMID: 32804147.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury. J Nucl Med. 2019 12; 60(12):1682-1690. Alcantara A, Berenji GR, Scherling CS, Durcanova B, Diaz-Aguilar D, Silverman DHS. PMID: 31601702.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018 10 01; 111:118-121. Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. PMID: 30006299.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    11. International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients. J Natl Cancer Inst. 2018 03 01; 110(3):223-231. Deprez S, Kesler SR, Saykin AJ, Silverman DHS, de Ruiter MB, McDonald BC. PMID: 29365201; PMCID: PMC6658857.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    12. Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline. Eur J Nucl Med Mol Imaging. 2017 Aug; 44(8):1355-1363. Torosyan N, Mason K, Dahlbom M, Silverman DHS, Alzheimer’sDisease Neuroimaging Initiative. PMID: 28331953.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care. Alzheimers Dement (Amst). 2016; 5:15-22. Apostolova LG, Haider JM, Goukasian N, Rabinovici GD, Chételat G, Ringman JM, Kremen S, Grill JD, Restrepo L, Mendez MF, Silverman DH. PMID: 28054024; PMCID: PMC5198877.
      View in: PubMed   Mentions: 19  
    14. Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Exp Gerontol. 2017 01; 87(Pt A):121-128. Lee J, Torosyan N, Silverman DH. PMID: 27856335.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    15. Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. J Clin Oncol. 2014 Nov 01; 32(31):3559-67. Ganz PA, Petersen L, Castellon SA, Bower JE, Silverman DH, Cole SW, Irwin MR, Belin TR. PMID: 25267747; PMCID: PMC4209106.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    16. Multimodal diagnosis of epilepsy using conditional dependence and multiple imputation. Int Workshop Pattern Recognit Neuroimaging. 2014 Jun; 1-4. Kerr WT, Hwang ES, Raman KR, Barritt SE, Patel AB, Le JM, Hori JM, Davis EC, Braesch CT, Janio EA, Lau EP, Cho AY, Anderson A, Silverman DH, Salamon N, Engel J, Stern JM, Cohen MS. PMID: 25311448; PMCID: PMC4188529.
      View in: PubMed   Mentions: 4  
    17. Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy. Psychiatry Res. 2014 Jul 30; 223(1):28-36. Rasgon NL, Kenna HA, Wroolie TE, Williams KE, DeMuth BN, Silverman DH. PMID: 24819305.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014 Jul 01; 20(13):3550-9. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, Elashoff D, Geist C, Silverman DH, Phelps ME, Chen W. PMID: 24687922; PMCID: PMC4079729.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    19. Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PLoS One. 2014; 9(3):e89095. Rasgon NL, Geist CL, Kenna HA, Wroolie TE, Williams KE, Silverman DH. PMID: 24622517; PMCID: PMC3951184.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    20. Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. Brain Imaging Behav. 2013 Dec; 7(4):363-73. Saykin AJ, de Ruiter MB, McDonald BC, Deprez S, Silverman DH. PMID: 24327327; PMCID: PMC3909524.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    21. The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. Clin Breast Cancer. 2014 Apr; 14(2):132-40. Hurria A, Patel SK, Mortimer J, Luu T, Somlo G, Katheria V, Ramani R, Hansen K, Feng T, Chuang C, Geist CL, Silverman DH. PMID: 24291380; PMCID: PMC4103787.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    22. Balancing Clinical and Pathologic Relevence in the Machine Learning Diagnosis of Epilepsy. Int Workshop Pattern Recognit Neuroimaging. 2013 Jun; 2013:86-89. Kerr WT, Cho AY, Anderson A, Douglas PK, Lau EP, Hwang ES, Raman KR, Trefler A, Cohen MS, Nguyen ST, Reddy NM, Silverman DH. PMID: 25302313; PMCID: PMC4188528.
      View in: PubMed   Mentions: 3  
    23. In-flight medical emergencies: creation of a novel simulation based medical student curriculum. Med Teach. 2013 Oct; 35(10):874. Katzer RJ, Frumin E, Silverman D, Koenig KL, Schultz CH. PMID: 24050198.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    24. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 2013 Jun 05; 105(11):791-801. Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DH, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR. PMID: 23606729; PMCID: PMC3672076.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    25. Computer-Aided Diagnosis and Localization of Lateralized Temporal Lobe Epilepsy Using Interictal FDG-PET. Front Neurol. 2013; 4:31. Kerr WT, Nguyen ST, Cho AY, Lau EP, Silverman DH, Douglas PK, Reddy NM, Anderson A, Bramen J, Salamon N, Stern JM, Cohen MS. PMID: 23565107; PMCID: PMC3615243.
      View in: PubMed   Mentions: 22  
    26. FDG-PET in early AD diagnosis. Med Clin North Am. 2013 May; 97(3):485-94. Chew J, Silverman DH. PMID: 23642583.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging. J Alzheimers Dis. 2013; 36(2):261-74. Smid LM, Kepe V, Vinters HV, Bresjanac M, Toyokuni T, Satyamurthy N, Wong KP, Huang SC, Silverman DH, Miller K, Small GW, Barrio JR. PMID: 23568102; PMCID: PMC3688653.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    28. Neuronuclear imaging in the evaluation of dementia and mild decline in cognition. Semin Nucl Med. 2012 Nov; 42(6):415-22. Torosyan N, Silverman DH. PMID: 23026363; PMCID: PMC4309799.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    29. A pilot study of the effects of meditation on regional brain metabolism in distressed dementia caregivers. Aging health. 2012 Oct 01; 8(5):509-516. Pomykala KL, Silverman DH, Geist CL, Voege P, Siddarth P, Nazarian N, St Cyr NM, Khalsa DS, Lavretsky H. PMID: 23378856; PMCID: PMC3558935.
      View in: PubMed   Mentions: 9  
    30. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative, Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, et al. PMID: 22343285; PMCID: PMC3309762.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    31. 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. J Nucl Med. 2012 Jan; 53(1):29-36. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W. PMID: 22159180; PMCID: PMC3424269.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    32. Neuroimaging and EEG-based explorations of cerebral substrates for suprapentasensory perception: a critical appraisal of recent experimental literature. Psychiatry Res. 2011 Nov 30; 194(2):105-10. Le C, Silverman DH. PMID: 21924873.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation. Neurosci Lett. 2011 Jan 10; 487(3):287-92. Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, Siu E, Cederbaum S, Hecimovic S, Malnar M, Chakraverty S, Goate AM, Bird TD, Leverenz JB. PMID: 21094210; PMCID: PMC3034479.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    34. Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry. 2011 Feb 15; 69(4):374-80. Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED. PMID: 21092938; PMCID: PMC3053132.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    35. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. J Nucl Med. 2010 Oct; 51(10):1532-8. Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W. PMID: 20847166.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    36. Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. Psychoneuroendocrinology. 2011 May; 36(4):502-13. Silverman DH, Geist CL, Kenna HA, Williams K, Wroolie T, Powers B, Brooks J, Rasgon NL. PMID: 20810219; PMCID: PMC3021636.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    37. Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Mol Imaging Biol. 2010 Apr; 12(2):218-24. Apostolova LG, Thompson PM, Rogers SA, Dinov ID, Zoumalan C, Steiner CA, Siu E, Green AE, Small GW, Toga AW, Cummings JL, Phelps ME, Silverman DH. PMID: 19636640; PMCID: PMC2844536.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    38. Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry. 2008 Dec; 16(12):999-1009. Small GW, Siddarth P, Silverman DH, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Huang SC, Barrio JR, Phelps ME. PMID: 19038899; PMCID: PMC2693408.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    39. Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in rats. Mol Imaging Biol. 2008 Nov-Dec; 10(6):341-8. Kesner AL, Hsueh WA, Czernin J, Padgett H, Phelps ME, Silverman DH. PMID: 18679756.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    40. Evaluating pathology in the brain with nuclear medicine. Semin Nucl Med. 2008 Jul; 38(4):225-6. Silverman DH. PMID: 18514078.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Advances in evaluation of primary brain tumors. Semin Nucl Med. 2008 Jul; 38(4):240-50. Chen W, Silverman DH. PMID: 18514080.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    42. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Semin Nucl Med. 2008 Jul; 38(4):251-61. Silverman DH, Mosconi L, Ercoli L, Chen W, Small GW. PMID: 18514081; PMCID: PMC4399815.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    43. Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow. J Appl Clin Med Phys. 2008 Jun 23; 9(3):147-156. Kesner AL, Lau VK, Speiser M, Hsueh WA, Agazaryan N, DeMarco JJ, Czernin J, Silverman DH. PMID: 18716585; PMCID: PMC5722291.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    44. Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenografts. J Nucl Med. 2007 Dec; 48(12):2021-7. Kesner AL, Hsueh WA, Htet NL, Pio BS, Czernin J, Pegram MD, Phelps ME, Silverman DH. PMID: 18006620.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    45. 3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Semin Nucl Med. 2007 Nov; 37(6):440-50. Seibyl JP, Chen W, Silverman DH. PMID: 17920351.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    46. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. J Clin Oncol. 2007 Oct 20; 25(30):4714-21. Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T. PMID: 17947718.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    47. Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7(8):514-7. Wiseman GA, Conti PS, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A. PMID: 18021468.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    48. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. J Nucl Med. 2007 May; 48(5):776-82. Lin TW, de Aburto MA, Dahlbom M, Huang LL, Marvi MM, Tang M, Czernin J, Phelps ME, Silverman DH. PMID: 17475967.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. Verbal memory retrieval deficits associated with untreated hypothyroidism. J Neuropsychiatry Clin Neurosci. 2007; 19(2):132-6. Miller KJ, Parsons TD, Whybrow PC, Van Herle K, Rasgon N, Van Herle A, Martinez D, Silverman DH, Bauer M. PMID: 17431058.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    50. Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. J Nucl Med. 2006 Dec; 47(12):1995-9. Hsueh WA, Kesner AL, Gangloff A, Pegram MD, Beryt M, Czernin J, Phelps ME, Silverman DH. PMID: 17138742.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    51. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007 Jul; 103(3):303-11. Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA. PMID: 17009108.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    52. Memory improvement with treatment of hypothyroidism. Int J Neurosci. 2006 Aug; 116(8):895-906. Miller KJ, Parsons TD, Whybrow PC, van Herle K, Rasgon N, van Herle A, Martinez D, Silverman DH, Bauer M. PMID: 16861154.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    53. Semiautomated analysis of small-animal PET data. J Nucl Med. 2006 Jul; 47(7):1181-6. Kesner AL, Dahlbom M, Huang SC, Hsueh WA, Pio BS, Czernin J, Kreissl M, Wu HM, Silverman DH. PMID: 16818953.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    54. Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. Am J Geriatr Psychiatry. 2006 Jun; 14(6):538-45. Small GW, Silverman DH, Siddarth P, Ercoli LM, Miller KJ, Lavretsky H, Wright BC, Bookheimer SY, Barrio JR, Phelps ME. PMID: 16731723.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    55. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006 Jun; 47(6):904-11. Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T. PMID: 16741298.
      View in: PubMed   Mentions: 163     Fields:    Translation:Humans
    56. Recognition and treatment of Alzheimer's disease: a case-based review. Am J Alzheimers Dis Other Demen. 2006 Mar-Apr; 21(2):119-25. Marseille DM, Silverman DH. PMID: 16634468.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol. 2006 Jan-Feb; 8(1):36-42. Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH. PMID: 16362149.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    58. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel. J Nucl Med. 2005 Nov; 46(11):1866-71. Gangloff A, Hsueh WA, Kesner AL, Kiesewetter DO, Pio BS, Pegram MD, Beryt M, Townsend A, Czernin J, Phelps ME, Silverman DH. PMID: 16269601.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    59. Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease. J Nucl Med. 2005 Oct; 46(10):1737-44. Pan XB, Wright TG, Leong FJ, McLaughlin RA, Declerck JM, Silverman DH. PMID: 16204725.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    60. 18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome. J Nucl Med. 2005 Sep; 46(9):1455-9. Tran A, Pio BS, Khatibi B, Czernin J, Phelps ME, Silverman DH. PMID: 16157527.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment. Breast Cancer Res Treat. 2005 Aug; 92(3):199-206. Castellon SA, Silverman DH, Ganz PA. PMID: 16155790.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    62. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med. 2005 Jun; 46(6):945-52. Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. PMID: 15937304.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    63. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med. 2005 Apr; 46(4):603-7. Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J. PMID: 15809482.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    64. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. J Nucl Med. 2005 Jan; 46(1):114-20. Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. PMID: 15632041.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    65. PET imaging in the assessment of normal and impaired cognitive function. Radiol Clin North Am. 2005 Jan; 43(1):67-77, x. Silverman DH, Alavi A. PMID: 15693648.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    66. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004 Nov-Dec; 6(6):411-6. Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J. PMID: 15564152.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    67. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med. 2004 May; 45(5):797-801. Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. PMID: 15136629.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    68. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med. 2004 Apr; 45(4):594-607. Silverman DH. PMID: 15073255.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    69. Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues. Cancer Treat Rev. 2004 Apr; 30(2):165-72. Silverman DH, Delpassand ES, Torabi F, Goy A, McLaughlin P, Murray JL. PMID: 15023434.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images. J Nucl Med. 2004 Feb; 45(2):290-3. Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J. PMID: 14960650.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease. Expert Rev Mol Diagn. 2004 Jan; 4(1):63-9. Chang CY, Silverman DH. PMID: 14711350.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Functional imaging as a window to dementia: corticobasal degeneration. J Neuropsychiatry Clin Neurosci. 2004; 16(4):393-9. Seritan AL, Mendez MF, Silverman DH, Hurley RA, Taber KH. PMID: 15616165.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    73. Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Mol Imaging Biol. 2004 Jan-Feb; 6(1):47-54. Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. PMID: 15018828.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab. 2003 Nov; 80(3):350-5. Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME. PMID: 14680983.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest. 2003 Aug; 124(2):608-13. Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C. PMID: 12907550.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    76. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 2003 Aug; 44(8):1238-42. Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J. PMID: 12902413.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    77. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. Mol Imaging Biol. 2003 Jul-Aug; 5(4):271-7. Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, Birnbaumer L, Phelps ME, Czernin J, Silverman DH. PMID: 14499142.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    78. Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Mol Imaging Biol. 2003 Jul-Aug; 5(4):232-9. Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J. PMID: 14499138.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    79. Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. Mol Imaging Biol. 2002 Jul; 4(4):283-93. Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME. PMID: 14537119.
      View in: PubMed   Mentions: 8     Fields:    
    80. The impact of 2-deoxy-2[18F] fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma: the referring physician's perspective. Mol Imaging Biol. 2002 Mar; 4(2):185-90. Wong C, Silverman DH, Seltzer M, Schiepers C, Ariannejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J. PMID: 14537142.
      View in: PubMed   Mentions: 4     Fields:    
    81. Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med. 2002 Mar; 43(3):325-9. Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J. PMID: 11884491.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    82. Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma. Cancer. 2002 Feb 15; 94(4 Suppl):1349-57. Wiseman GA, Leigh B, Erwin WD, Lamonica D, Kornmehl E, Spies SM, Silverman DH, Witzig TE, Sparks RB, White CA. PMID: 11877765.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    83. Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma. Semin Oncol. 2002 Feb; 29(1S2):87-92. Gordon LI, Witzig TE, Wiseman GA, Flinn IW, Spies SS, Silverman DH, Emmanuolides C, Cripe L, Saleh M, Czuczman MS, Olejnik T, White CA, Grillo-López AJ. PMID: 28140097.
      View in: PubMed   Mentions: 2     Fields:    
    84. Assessing brain biochemistry in the early evaluation of dementia: can we afford the improved diagnostic accuracy obtained by incorporating cerebral metabolic data acquired with positron emission tomography into the clinical work-up? Mol Imaging Biol. 2002 Jan; 4(1):5-9. Silverman DH, Phelps ME. PMID: 14538044.
      View in: PubMed   Mentions:    Fields:    
    85. Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease. Clin Positron Imaging. 1999 May; 2(3):119-130. Silverman DH, Small GW, Phelps ME. PMID: 14516535.
      View in: PubMed   Mentions: 21  
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Daniel's Networks
    Concepts (300)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (76)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California